Bioleaching of arsenic (As)-rich, so-called “dirty” concentrates can produce additional Cu value from the flotation waste while simultaneously releasing toxic As. This study bioleached three such concentrates of varying pyrite/enargite ratios ([Py]/[Ena] = 0.7, 1.3 and 2.4) at a pulp density of 20%. The dissolution behavior of Cu and As in relation to the solution redox potential (Eh) was studied with and without activated carbon (AC) as a potential Eh-controlling catalyst. At this high pulp density, Eh was naturally suppressed, without a need for AC dosing, to <700 mV (a rapid pyrite dissolution is prevented in this Eh range). The effect of AC dosing on Eh varied depending on the type of concentrate; Eh was further reduced only in the case of the most enargite-rich concentrate, DC-I. Among the three concentrates, the highest Cu dissolution (35%) was seen in DC-I (without AC dosing), which simultaneously achieved the lowest As solubilization. Arsenic was immobilized as amorphous precipitates, likely in a mixture of ferric arsenate, cupric arsenate, basic ferric sulfate and sulfur. Arsenic immobilization became increasingly ineffective as the pyrite content increased in the concentrate. Based on these results, setting a lower [Py]/[Ena] ratio prior to the dirty concentrate bioleaching could be a useful approach to promote Cu dissolution and As immobilization simultaneously.

Overcoming the slow-leaching kinetics of refractory primary copper sulfides is crucial to secure future copper sources. Here, the effect of carbon was investigated as a catalyst for a bioleaching reaction. First, the mechanism of carbon-assisted bioleaching was elucidated using the model chalcopyrite mineral, under specified low-redox potentials, by considering the concept of Enormal. The carbon catalyst effectively controlled the Eh level in bioleaching liquors, which would otherwise exceed its optimal range (0 ≤ Enormal ≤ 1) due to active regeneration of Fe3+ by microbes. Additionally, Enormal of ~0.3 was shown to maximize the carbon-assisted bioleaching of the model chalcopyrite mineral. Secondly, carbon-assisted bioleaching was tested for three types of chalcopyrite/enargite-bearing complex concentrates. A trend was found that the optimal Eh level for a maximum Cu solubilization increases in response to the decreasing chalcopyrite/enargite ratio in the concentrate: When chalcopyrite dominates over enargite, the optimal Eh was found to satisfy 0 ≤ Enormal ≤ 1. As enargite becomes more abundant than chalcopyrite, the optimal Eh for the greatest Cu dissolution was shifted to higher values. Overall, modifying the Eh level by adjusting AC doses to maximize Cu solubilization from the concentrate of complex mineralogy was shown to be useful.

JAV1-associated ubiquitin ligase 1 (JUL1) is a RING-type E3 ubiquitin ligase that catalyzes ubiquitination of JAV1, a jasmonate signaling repressor, in Arabidopsis thaliana in response to herbivore attack. Here we present a new insight into the nature of JUL1 as a multi-targeting enzyme for not only JAV1 but also transcription factors (TFs) screened using in vitro and in vivo protein interaction assays. Reporter assays using protoplasts showed that the JUL1-interacting TFs (JiTFs), including ERF15, bZIP53 and ORA59, were involved in transcriptional activation of jasmonate-responsive PDF1.2 and abscisic acid-responsive GEA6. Likewise, assays using mutant plants suggested that the 3 JiTFs were indeed responsible for transcriptional regulation of PDF1.2 and/or GEA6, and ERF15 and ORA59 were substantially responsible for the anti-herbivore trait. In vitro protein ubiqutination assays showed that JUL1 catalyzed ubiqutination of JAV1 but not any of the TFs. This was in accord with the finding that JUL1 abolished JAV1′s interference with ERF15 function, according to the reporter assay. Moreover, of great interest is our finding that ERF15 but not bZIP53 or ORA59 serves as a scaffold for the JAV1/JUL1 system, indicating that there is narrow selectivity of the transcriptional reprogramming by the JAV1/JUL1 system.

No abstract

No abstract